Pediatric Cancer: Clinical Trials

24 trials for Pediatric Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 recruiting, 5 completed, 3 unknown, 2 terminated. 24 Phase 2, 9 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 224Recruiting 10, Completed 5, Unknown 3, Terminated 2, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1
Phase 19Recruiting 5, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 34Completed 2, Unknown 2

Follow Pediatric Cancer: new trials by email Literature Review of Pediatric Cancer trials Research Report on Pediatric Cancer

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
sonrotoclax, Azacitidine, Inotuzumab ozogamicin - Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Phase 1 / Phase 2Not yet recruitingBeOne Medicines302026-12-012026-10-26
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
BCB-276 - Diffuse Intrinsic Pontine Glioma, DIPG
Phase 2RecruitingBrainChild Bio, Inc752026-09-042026-10-28
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Selpercatinib Monotherapy, 131I Therapy - Differentiated Thyroid Cancer, Pediatric Cancer
Phase 2RecruitingChildren's Hospital of Philadelphia132024-07-292026-07-24
Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
Pucotenlimab - Rhabdomyosarcoma, Pediatric Cancer
Phase 1 / Phase 2RecruitingSun Yat-sen University822024-06-062024-06-13
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Larotrectinib monotherapy, 131I therapy - Differentiated Thyroid Cancer, Pediatric Cancer
Phase 2RecruitingChildren's Hospital of Philadelphia132024-02-142026-10-21
Pediatric Oncology Nutrition Intervention Trial
Oral Nutrition Supplement, Tube Feed, Cyproheptadine - Pediatric Cancer, Nutrition Related Cancer
Phase 2 / Phase 3CompletedCorey Hawes202024-01-312026-10-08
Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
Arsenic trioxide - Pediatric Cancer, Li-Fraumeni Syndrome
Phase 2RecruitingYang Li502023-12-132024-01-03
Lurbinectedin in FET-Fused Tumors
Lurbinectedin - Ewing Sarcoma, Desmoplastic Small Round Cell Tumor
Phase 1 / Phase 2RecruitingChildren's Hospital of Philadelphia632023-07-272026-09-02
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Atezolizumab, Sorafenib, Bevacizumab - Refractory Solid Tumor, Hepatocellular Carcinoma
Phase 1 / Phase 2RecruitingSt. Jude Children's Research Hospital642022-11-072026-05-19
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
Vaccine - Pediatric Cancer
Phase 2RecruitingWake Forest University Health Sciences642022-08-082026-07-23
Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)
PROMISE (Pediatric Radiation Oncology with Movie Induced Sedation Effect) - Pediatric Cancer
Phase 2CompletedUniversity of Texas Southwestern Medical Center302022-08-012026-03-02
Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients
Fosaprepitant,ondansetron, dexamethasone, placebo ondansetron with dexamethasone - Pediatric Cancer
Phase 2CompletedSun Yat-sen University1082022-08-012024-01-09
Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy
PD-1 inhibitor - Transitional Cell Tumor, Hepatoblastoma
Phase 2 / Phase 3UnknownRenJi Hospital152022-04-102022-04-11
Comparing TIVA Using Propofol or Dexmedetomidine Versus Sevoflurane During Anaesthesia of Children Undergoing Bone-Marrow Aspiration
Sevoflurane, Propofol infusion for maintance, Dexmedetomidine - Invasive Cancer, Pediatric Cancer
Phase 2 / Phase 3CompletedAlexandria University602022-02-152022-12-05
Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy
pegylated recombinant human granulocyte-colony stimulating factor - Pediatric Cancer
Phase 2UnknownSun Yat-sen University1082020-10-102021-09-02
Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy
Warm Baths or Showers, Moisturizer, SPF 30 or Higher Suncreen - Pediatric Cancer, CNS Tumor, Childhood
Phase 2CompletedDana-Farber Cancer Institute142020-10-012026-06-12
Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma
Famitinib, Ifosfamide, Camrelizumab - Effect of Drugs, Progression
Phase 1 / Phase 2WithdrawnPeking University People's Hospital2019-08-152020-05-19
A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia
Tranexamic Acid, Normal saline - Pediatric Cancer, Thrombocytopenia
Phase 1 / Phase 2TerminatedMeghan McCormick112019-04-222021-09-20
Durvalumab and Tremelimumab for Pediatric Malignancies
Durvalumab / Tremelimumab Combination Therapy - Pediatric Cancer, Solid Tumor Pediatric
Phase 1 / Phase 2Active not recruitingAstraZeneca502019-03-072026-09-29
the Efficacy and Safety of Sugammadex in Children 0-2 Years Old
Sugammadex - Anesthesia, Pediatric Cancer
Phase 2 / Phase 3UnknownFederal Research Institute of Pediatric Hematology, Oncology and Immunology622018-11-152018-11-02

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Neoplasms (24)  ·  Central Nervous System Neoplasms (2)  ·  Hepatoblastoma (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Thyroid Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Hepatocellular (1)  ·  Child Nutrition Disorders (1)  ·  Dermatitis (1)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Disease Progression (1)  ·  Fibrolamellar hepatocellular carcinoma (1)  ·  Hematologic Neoplasms (1)

Broader conditions

Neoplasms by Histologic Type (8)  ·  Neoplasms by Site (7)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Nervous System Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Disease Attributes (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Head and Neck Neoplasms (2)  ·  Immune System Diseases (2)

Interventions

Cyclophosphamide (3)  ·  Dexamethasone (3)  ·  camrelizumab (2)  ·  AZD 6244 (1)  ·  Arsenic Trioxide (1)  ·  Azacitidine (1)  ·  Bevacizumab (1)  ·  CYC065 (1)  ·  Calcium Dobesilate (1)  ·  Carboplatin (1)  ·  Cyproheptadine (1)  ·  Cytarabine (1)  ·  Dexmedetomidine (1)  ·  Educational Status (1)  ·  Enteral Nutrition (1)

Sponsors

Children's Hospital of Philadelphia (3)  ·  Sun Yat-sen University (3)  ·  Alexandria University (1)  ·  AstraZeneca (1)  ·  BeOne Medicines (1)  ·  BrainChild Bio, Inc (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Corey Hawes (1)  ·  Dana-Farber Cancer Institute (1)  ·  Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  M.D. Anderson Cancer Center (1)  ·  Meghan McCormick (1)  ·  Peking University People's Hospital (1)  ·  RenJi Hospital (1)

Countries

United States (13)  ·  China (6)  ·  Denmark (2)  ·  France (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Egypt (1)  ·  Finland (1)  ·  Germany (1)  ·  Russia (1)

Top investigators

Theodore Laetsch, MD (3)  ·  Yizhuo Zhang (2)  ·  Anna Franklin, MD (1)  ·  Anna Konstantinova, MD (1)  ·  Ashley Hinson, MD (1)  ·  Ashok Gupta, MD, PhD (1)  ·  Birgit Geoerger, MD (1)  ·  Corey J Hawes, DCN, RD, CSO, CNSC, LD (1)  ·  Cori Abikoff, MD (1)  ·  Hao Feng (1)  ·  Jennifer Huang, MD (1)  ·  Jessica Gartrell, MD (1)  ·  Kiran A Kumar, MD (1)  ·  Marisa Couluris, DO (1)  ·  Meghan McCormick, MD (1)

Results publications

PMID 29587881, PMID 31538815, PMID 32005489, PMID 33892407, PMID 34347542, PMID 34533416, PMID 34543871, PMID 35292802, PMID 37183837, PMID 41838385, PMID 42222420, PMID 42686334

NIH funding

2016 (1), 2018 (1), 2023 (1), UL1TR001998 (1)